Cargando…
Understanding on CRISPR/Cas9 mediated cutting-edge approaches for cancer therapeutics
The research focus on CRISPR/Cas9 has gained substantial concentration since the discovery of ‘an unusual repeat sequence’ reported by Ishino et al. (J Bacteriol 169:5429–5433, 1987) and the journey comprises the recent Nobel Prize award (2020), conferred to Emmanuelle Charpentier and Jennifer Doudn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174617/ https://www.ncbi.nlm.nih.gov/pubmed/35674844 http://dx.doi.org/10.1007/s12672-022-00509-x |